greeksoup/ stock research

Labcorp Holdings (LH) FY2021 results: revenue $13.1 billion, down 6.0% on the year

Labcorp Holdings Inc. (LH) reported revenue of $13.1 billion for fiscal 2021, the year ended 31 December 2021, down 6.0% on the year before. Net income was $2.4 billion, up 52.8%, and diluted earnings per share $24.39. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2022.

Revenue
$13.1 billion
-6.0% on the year
FY2014FY2021
Operating margin
23.2%
17.5% a year earlier
FY2014FY2021
Net income
$2.4 billion
+52.8% on the year
FY2014FY2021
Diluted EPS
$24.39
+53.6% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue13,13613,97811,555-6.0%
Cost of revenue8,1449,0268,302-9.8%
Gross profit4,9924,9533,252+0.8%
Gross margin38.0%35.4%28.1%
Selling, general and administrative1,6901,7291,624-2.3%
Operating income3,0492,4451,330+24.7%
Operating margin23.2%17.5%11.5%
Interest expense212207241+2.3%
Income tax690662280+4.2%
Net income2,3771,556824+52.8%
Net margin18.1%11.1%7.1%
Diluted EPS$24.39$15.88$8.35+53.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow3,1102,1351,445+45.6%
Capital expenditure422382400+10.4%
Free cash flow2,6881,7541,044+53.3%
Free cash flow margin20.5%12.5%9.0%
Cash from investing-885-643-1,283
Cash from financing-2,066-517-253
Depreciation and amortisation577625577-7.6%
Share-based compensation133112107+19.0%
Buybacks1,668100450+1,568.5%
Dividends paid0.00.0n/a
Diluted shares, weighted98m98m99m-0.5%
Shares outstanding at period end98m98m97m0.0%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity10,2739,4377,644+8.9%
Debt5,4165,7966,205-6.5%
Operating lease liabilities642678597-5.2%
Finance lease liabilities84.684.491.1+0.2%
Other liabilities3,9684,0773,510-2.7%
Total liabilities and equity20,38520,07218,046+1.6%
Fixed assets2,8152,7302,637+3.1%
Goodwill5,8917,7527,865-24.0%
Intangible assets3,7363,9614,034-5.7%
Cash and equivalents1,4731,321338+11.5%
Receivables2,2622,4801,544-8.8%
Inventory401423245-5.2%
Other assets3,8081,4061,384+170.9%
Total assets20,38520,07218,046+1.6%

10-K for the year ended 31 December 2021, filed 25 February 2022: the filing.